BMS Scholar Helps Lead Team Studying Worldwide Patented Innovations Available for Gene Therapy Treatment

diagram of cells
This illustration shows how a team of scientists from Purdue University and institutions around the world have come together to better understand the growing number of worldwide patented innovations available for gene therapy treatment. (Image provided)

The global gene therapy market is expected to reach $13 billion by 2024 as new treatment options target cancers and other diseases. Dr. Marxa Figueiredo, associate professor of basic medical sciences in the Purdue University College of Veterinary Medicine, has helped lead a team of scientists from Purdue and other research institutions around the world who came together to better understand the growing number of worldwide patented innovations available for gene therapy treatment.

Dr. Figueiredo and her fellow team members specifically focus on nonviral methods, which use synthetic or natural compounds or physical forces to deliver materials generally less toxic than their viral counterparts into the therapy treatments. “The possibility of using nonviral vectors for gene therapy represents one of the most interesting and intriguing fields of gene therapy research,” said Dr. Figueiredo, who works with the Purdue Research Foundation Office of Technology Commercialization to patent her technologies related to health. “This is an innovative method for identifying the technological routes used by universities and companies across the world and uncovering emerging trends for different gene therapy sectors.”

The scientists used big data, patent, and clinical data mining to identify technological trends for the gene therapy field. The team’s work is presented in the February 7 edition of Nature Biotechnology. They envision that their analysis will help guide future developments for gene therapy.

The research project brought together investigators from across the globe in a joint effort to use new databases and methods to better understand the trends of the gene therapy field in respect to nonviral vectors. Dimas Covas, coordinator of the Center for Cell-based Therapy, affiliated with the University of São Paulo in Brazil, lent his extensive experience in cell therapy. Dr. Figueiredo, Aglaia Athanassiadou, and Virginia Picanço-Castro contributed their extensive experience with nonviral vectors for gene therapy. Cristiano Pereira and Geciane Porto brought their expertise in economics and business administration to the analyses. Each contribution was fundamental to achieving a new way to identify technological trends in this field.

“This work brought together investigators from very diverse disciplines to create a different perspective on the gene therapy field,” Dr. Figueiredo explained. “Our groups continue to work individually or in collaboration to generate and patent new vectors to help fill the needs of this re-emerging field of nonviral gene therapy.”

The Purdue Research Foundation Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by the office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. 

Click here to view a complete news release about the research

Writer(s): Kevin Doerr | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

This week we offer a very special “Paws Up” to Dr. Kathy Salisbury as she nears retirement as Associate Dean for Academic Affairs and concludes a remarkable career during which she gave more than 40 years of dedicated and steadfast service to the veterinary profession, the College of Veterinary Medicine and Purdue University.

Petula the Papillon: from Heartache to Healing and Beyond

Our series of articles about animals and their owners who’ve found help and healing at the Purdue University Veterinary Hospital continues as we share the story of Petula, the Papillon. Ann Bruno will never forget the moment her Papillon puppy, Petula, jumped out of the bath and landed wrong. In an instant, her young agility partner could not put weight on her leg. Ann’s heart sank. Petula was more than a beloved companion. She was already in training for agility competitions, and Ann was determined to do everything she could to get her back on track.

2025 Purdue Veterinary Conference to Feature Top-Level Continuing Education and Events

The Purdue University College of Veterinary Medicine is set to host the 2025 Purdue Veterinary Conference September 16–20, and registration is open! The annual event held on Purdue’s West Lafayette campus brings together veterinary professionals, educators, students, and industry partners for a week of continuing education complete with opportunities for practical learning, collaboration and networking.

In Memory: Dr. Jennifer Anderson-Schmeltz (PU DVM 2009)

The Purdue Veterinary Medicine community is deeply saddened to learn of the passing of a member of the Purdue DVM Class of 2009, Dr. Jennifer Anderson-Schmeltz, of Mishawaka, Indiana, who died June 13 after a courageous battle with cancer. She was 42.